Response to Office Action

PTO Form 1957 (Rev 5/2006)

OMB No. 0651-0050 (Exp. 04/2009)

---

PTO Form 1957 (Rev 5/2006)

OMB No. 0651-0050 (Exp. 04/2009)

Response to Office Action

To the Commissioner for Trademarks:

Application serial no. 78260879 has been amended as follows:
Classification and Listing of Goods/Services

Applicant hereby amends the following class of goods/services in the application as follows:
Current: Class 005 for Gene therapy and prophylaxis products, namely, gene delivery products; pharmaceutical substances and preparations for use in the medical industry, namely vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, retroviral vector and retroviral vector manufacturing preparations, all for use in gene delivery technologies; vector production technologies and neurogenomics products; chemical products for use in medical science, particularly for treatment of disease of the eye, vascular and neovascularisation disorders and retinopathy; pharmaceutical and biochemical preparations for the treatment of macular degeneration and retinopathy and angiogenesis
Original Filing Basis: 1(b); and/or 44(e).
Proposed: Class 005 for Gene therapy and prophylaxis products, namely, gene delivery products; pharmaceutical substances and preparations for use in the medical industry, namely vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, retroviral vector and retroviral vector manufacturing preparations, all for use in gene delivery technologies, vector production technologies and neurogenomics products; chemical products for use in medical science, particularly for treatment of disease of the eye, vascular and neovascularisation disorders and retinopathy; pharmaceutical and biochemical preparations for the treatment of macular degeneration and retinopathy and angiogenesis
Applicant hereby amends the following class of goods/services in the application as follows:
Current: Class 042 for Scientific and medical research and development; engineering services, biotechnology services, namely, biotechnology research in the development of therapeutic and prophylactic products and vaccines; licensing of intellectual property; advisory services relating to gene therapy products; medical research and development in the field of vector production technologies
Original Filing Basis: 1(b); and/or 44(e).
Proposed: Class 042 for Scientific and medical research and development; engineering services, biotechnology services, namely, biotechnology research in the development of therapeutic and prophylactic products and vaccines; licensing of intellectual property; advisory services relating to the research and development of gene therapy products; medical research and development in the field of vector production technologies

Declaration Signature
I hereby elect to bypass the submission of a signed declaration, because I believe a declaration is not required by the rules of practice. I understand that the examining attorney could still, upon later review, require a signed declaration.
Response Signature

Signature: /daniellemattessich/     Date: 04/20/2006
Signatory's Name: Danielle I. Mattessich
Signatory's Position: Attorney
        
Serial Number: 78260879
Internet Transmission Date: Thu Apr 20 16:01:30 EDT 2006
TEAS Stamp: USPTO/ROA-XX.XXX.XXX.XXX-200604201601309
88053-78260879-320c05c4b30109f6e144fb492
8887e577fa-N/A-N/A-20060420155707949975